The UK PM Theresa May’s office has asked companies listed in the blue-chip FTSE 100 index to a public letter welcoming the government’s efforts of making Brexit a success.
But this request is not getting digested well with big corporates in the country.
Britain’s second-biggest pharmaceuticals company AstraZeneca’s CEO Pascal Soriot who is leaving the chair of the company has denied to sign the letter. He said that the reason behind not signing a letter is the uncertainty over the situation and terms and conditions.
He cleared that his denial does not mean he disagrees with Brexit. He said he worries about the trade agreements after Brexit which is barely 18 months away.